Prostamax
Khavinson tetrapeptide bioregulator (Lys-Glu-Asp-Pro) for prostate tissue gene expression and male reproductive endocrinology research
Select size
For research purposes only. Not for human consumption.
Mechanism of Action
Prostamax is a Khavinson short-chain peptide bioregulator built around the tetrapeptide Lys-Glu-Asp-Pro (KEDP), derived from research on prostate tissue extracts. Khavinson peptides are proposed to act as tissue-specific gene-expression regulators that penetrate cell and nuclear membranes and bind directly to promoter regions of DNA to modulate transcription in their target organ.
How It Works
- 1
Selectively targets prostate tissue gene expression pathways
- 2
Proposed to bind specific DNA promoter regions to modulate transcription
- 3
Supports normalization of prostate epithelial and stromal cell function in research models
- 4
Modulates androgen-pathway and inflammatory gene expression in prostate tissue
- 5
Studied for restoring functional activity in aged or stressed prostate tissue
Key Research Benefits
- Prostate tissue bioregulation research
- Male reproductive endocrinology studies
- Benign prostatic hyperplasia (BPH) model investigation
- Chronic prostatitis pathway research
- Age-related prostate function studies
- Tissue-specific peptide bioregulator exploration
Prostamax belongs to the Khavinson family of short peptide bioregulators developed at the St. Petersburg Institute of Bioregulation and Gerontology. Russian research has explored its use in prostate-tissue normalization and age-related prostate dysfunction models. For research use only — not for human consumption.